Member Info for Santhi123

Thanks itsall 😁

Really sorry can the person who shared the finish chat forum re send the link. Much appreciated!

Yes, noticed they are happy to take 20000 shares in one go . Wonder if FOMO will start to kick in soon

Out of curiosity, Ddo you own any Faron shares Koozer?

Things starting to get really exciting here!

NAS already 5% up. Could be last chance under £2

That makes sense, thanks Sax.

I too remember humungous being thrown out.

Blue sky thinking would be life changing for most of us!

Imo it looks like a buy as the price was around 178 to buy all day yesterday.

The sell price most of the day was around 174.

If it was a buy I’m very surprised we didn’t see a bigger tick up though.

Well Timo adding has taken away any concerns that we won’t do well here.

After 6 years holding and adding, is x mas finally coming early 🙏

Surely now it’s only a matter of time before we make a positive move regarding the sp!

Just bought another 500 odd shares.

I’m all in now! No more left to give….

Https://www.inderes.fi/videos/faron-esmo-2025

For anyone interested!

Good question. Did they not have to wait so many months before they could start exercising them?

Just bought my final 1k top up! Folllow the money as they say…..

So Timo has bought more! Happy days. Diamond hands required

17.8p now……..

Talking utter garbage once again James.

You can buy 18.48p no issues right now.

So much for this going over 50p today 😂

Did anyone manage to watch the presentation?

Some decent buying going on in the NAS right now 😁

Looks promising!

From Petri on linked in.

ESMO Day 1! 🚀

Kicking off four days top-notch science here in Berlin — the world’s best all gathered together!

And very importantly: Faron’s Oral presentation coming up Sunday morning, presented by study PI Mika Kontro. Updated bexmarilimab efficacy, PK and PD data in MDS pts coming out. The responses are deepening and data just keeps on maturing for better.Stay tuned — more to come! 🔥#ESMO2025 #BEXMAB #Bexmarilimab #Bex #Clever1 #novelimmunotherapy #CancerResearch

📢 Faron Pharmaceuticals at ESMO 2025 – Berlin

ESMO 2025 kicks off today in Berlin, and we’re excited to be presenting new clinical and translational data from our BEXMAB study. Petri Bono and Aneel Nimba from Faron will be attending, joining global oncology leaders to share insights and explore innovations in cancer care.

🗣️ Sunday, October 19 | Mini Oral Abstract Session

Title: Pharmacokinetic and pharmacodynamic insights from the BEXMAB study evaluating bexmarilimab + azacitidine in higher-risk myelodysplastic syndromes (HR-MDS)

Presenter: Dr. Mika Kontro, Associate Professor at University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Department of Hematology

This marks the first full disclosure of PK/PD data from the BEXMAB study, alongside promising efficacy and biomarker findings. The data supports bexmarilimab’s advancement into Phase III and highlights its potential to address unmet needs in HR-MDS through macrophage reprogramming and immune activation.

We invite ESMO attendees to join the session and explore how targeting Clever-1 may reshape the treatment landscape for myeloid malignancies.

#ESMO2025 #BEXMAB #Bexmarilimab #Clever1 #Immunotherapy

#CancerResearch #Biotech #ClinicalDevelopment